Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Equipment Goes on the Block

NEW YORK, Aug. 26 (GenomeWeb News) - Deltagen, which filed for Chapter 11 bankruptcy in June, will auction the lab equipment from its 132,000-square foot Redwood City, Calif., facility on October 15 and 16, according to auctioneer and liquidator AuctioNet.


A pre-auction sale of the equipment, which includes ABI DNA sequencers, Agilent microarray scanners, autoclaves, sterilizers, test equipment, optical inspection equipment, IT equipment, and executive office furnishings, began on August 15.


The pre-auction sale and the live auction event are by order of the US Bankruptcy Court, Northern California.

According to Nuri Otus, CEO of AuctioNet, the Deltagen auction will be "the largest sales event the biotechnology industry has ever seen."


The live auction will be held at Deltagen's facility and will also be featured on eBay's Business & Industrial Live Online Auctions. More information about the sale is available here.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.